Figure 4.
Forest plot of unadjusted odds ratios for mortality at 3 months in patients with and without adjunctive administration of IAF during MT. *For Anadani et al we used PH2 as sICH surrogate. IAF, intra-arterial fibrinolytics; MT, mechanical thrombectomy; PH2, parenchymal hematoma type 2; sICH, symptomatic intracranial hemorrhage; tPA, tissue plasminogen activator; uPA, urokinase.